Under construction – not a live service
Sign in
Taking people in GreeceNo phase

Tests heart ultrasound stress results against later coronary angiography findings

Follows adults with coronary artery disease whose stress echocardiography showed heart ischemia.

Plain-language title generated from the registry record
Registry title: The Positive Prognostic Value of Stress Echocardiography - AMPHIPOLIS STUDY

Key facts

Where
Athens, GreeceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Source: NCT06839755, who can take part

Where in Greece

  • Hellenic Society of CardiologyAthens, GreeceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Hellenic Society of Cardiology
Trial code
NCT06839755
Record updated
21 February 2025
Original description
This is a prospective, multicenter, observational study of patients with recent stress echocardiography positive for myocardial ischemia. Up to now 25 echocardiography labs form Greece and Cyprus have declared their intention to participate. The investigators will enroll 390 patients with a positive stress echo, who will undergo invasive coronary angiogram and then will be followed up for at least 6 months. The objectives are the following:Read full original descriptionShow less

The Prognostic Value of Positive Stress Echocardiography and Its Relationship with Invasive Coronary Angiography: the AMPHIPOLIS Study

This is a prospective, multicenter, observational study of patients with recent stress echocardiography positive for myocardial ischemia. Up to now 25 echocardiography labs form Greece and Cyprus have declared their intention to participate. The investigators will enroll 390 patients with a positive stress echo, who will undergo invasive coronary angiogram and then will be followed up for at least 6 months. The objectives are the following:

1. To assess the prognostic value of positive stress echo by monitoring for cardiovascular death and major adverse cardiovascular events (MACE) during the follow-up. 2. To investigate the relationship of stress echo findings with invasive coronary angiography anatomical findings. 3. The association of cardiovascular risk profile of participants with stress echo and coronary angiography findings.

Inclusion: Patients with recent stress echocardiography positive for any extent of myocardial ischemia.

Exclusion: Concomitant chronic diseases reducing life expectancy (active cancer, severe liver impairment, auto-immune diseases etc); Any symptomatic valvular disease causing symptoms; Recent acute coronary syndrome the last week; HFrEF requiring viability study; Established or suspected cardiomyopathy.

ClinicalTrials.gov NCT06839755